Clinical & translational oncology

• 

  Año 2025, Vol. 27, Número 5

  • REVIEW ARTICLE

    • Genetic profile of ferroptosis in non‑small cell lung carcinoma and pharmaceutical options for ferroptosis induction

      Rohil Jawed, Huma Bhatti, Adnan khan

      • Resumen

      págs. 1867-1886

      

    • Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers

      Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, Nasim Ebrahimi, Amir Reza Aref

      • Resumen

      págs. 1887-1920

      

    • Intratumoral microbiota: a new force in the development and treatment of esophageal cancer

      Tianyang Jing, Dong Tang

      • Resumen

      págs. 1921-1932

      

    • Functional and therapeutic significant of heat‑shock protein 90 (HSP90) in reproductive cancers

      Ben Zhen He, Liang Wang

      • Resumen

      págs. 1933-1942

      

    • Tumor microenvironment as a complex milieu driving cancer progression: a mini review

      Zhengrui Li, Jing Li, Xiaolei Bai, Xufeng Huang, Qi Wang

      • Resumen

      págs. 1943-1952

      

    • Shugoshin 1 expression in various cancers: a potential target for therapy

      Indumathi Ankathatti Narayanaswamy, Abhay Kumaraswamy Kattepur, Kalyani Raju, Venkatachalam Perumal, Ravi Ramalingam, Venkateswarlu Raavi

      • Resumen

      págs. 1953-1966

      

  • RESEARCH ARTICLE

    • Analysis of genomic alternations in epidermal growth factor receptor (EGFR)‑T790M‑mutated non‑small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy

      Ping Chih Hsu, John Wen Cheng Chang, Li Chung Chiu, Cheng Ta Yang, Scott Chih Hsi Kuo, Yueh Fu Fang, Chiao En Wu

      • Resumen

      págs. 1967-1979

      

    • Scoping review of anticancer drug utilization in lung cancer patients at the end of life

      Endre Szigethy, Mohammed Merzah, Ivan Solà Arnau, G. Urrutia Cuchi, X. Bonfill

      • Resumen

      págs. 1980-1993

      

    • Intratumoral and peritumoral radiomics model for the preoperative prediction of cribriform component in invasive lung adenocarcinoma: a multicenter study

      Miaomiao Lin, Kai Li, Yanni Zou, Haipeng Huang, Xiang Zhao, Siyu Yang, Chunli Zhao

      • Resumen

      págs. 1994-2004

      

    • Combining serum CDK1 with tumor markers for the diagnosis of small cell lung cancer

      Kexin Han, Yinyi Chen, Xinlu Sun, Lili Wen, Yang Wu, Simei Chen, Liping Wei, Jianlin Yu, Tingting Zeng, Lei Jiang, Liming Tan

      • Resumen

      págs. 2005-2013

      

    • Synergistic efects of combined hyperthermia and electric felds treatment in non‑small cell lung‑cancer (NSCLC) cell lines

      Jinju Heo, Yunhui Jo, Myonggeun Yoon

      • Resumen

      págs. 2014-2023

      

    • Pemetrexed and platinum with or without pembrolizumab for advanced non‑small‑cell lung cancer (NSCLC): a systematic review and meta‑analysis

      Zichen Zhao, Chuchu Yang, Jiashu Li

      • Resumen

      págs. 2024-2036

      

    • Certifcation system for multidisciplinary thoracic tumour boards

      Mariano Provencio Pulla, Juan José Arenas Jiménez, Ángel Cilleruelo Ramos, Alberto Fernández Villar, Antonio Gómez Caamaño, María Guirado, Jose Antonio Marques Magallanes, Lara Pijuán Andújar, A. Sánchez, Cristina Teixidó Vargas, Bartomeu Massuti Sureda

      • Resumen

      págs. 2037-2040

      

    • IORT‑photon boost plus hypofractionated whole breast irradiation in patients with breast cancer after primary systemic treatment: feasibility, safety and clinical results

      J. Burgos Burgos, Víctor Vega Benítez, David Macias Verde, E. Vicente, C. Murias, C. Santana, Pedro Lara Jiménez

      • Resumen

      págs. 2054-2059

      

    • Metformin boosts doxorubicin efcacy and increases CD8+T cell frequency in mouse breast cancer

      Elaheh Hassani, Sahand Mozzendizaji, Vahid Shafei Irannejad, Adel Mohammadzadeh

      • Resumen

      págs. 2060-2066

      

    • UBE2T is a diagnostic and prognostic biomarker for endometrial cancer

      Longyun Wang, Mengqi Wang, Zeyu Wang, Kai Wang, Bowei Zhao, Yue Wang, Jingying Zheng, Shuang Zhang

      • Resumen

      págs. 2067-2083

      

    • Inhibiting SNX10 induces autophagy to suppress invasion and EMT and inhibits the PI3K/AKT pathway in cervical cancer

      Dan Liao, Yanxian He, Bin He, Saitian Zeng, Yejia Cui, Cuifen Li, Haohai Huang

      • Resumen

      págs. 2084-2094

      

    • Prevention of radiation induced dermatitis in head and neck cancer patients using cryptomphalus aspersa secretion

      Adriana Fondevilla Soler, Elena Moreno, Juana María Bernal, María-José Belmonte, Antonio Nicolás, E. López Ramírez

      • Resumen

      págs. 2095-2103

      

    • Salvage reirradiation for recurrent glioblastoma: a retrospective case series analysis

      Anna Lucas Calduch, Miquel Maciá i Garau, Salvador Villà Freixa, Nagore García Expósito, Ignasi Modolell, Carles Majós Torró, Albert Pons Escoda, Carlos Mesía Barroso, Noelia Vilariño Quintela, Aleix Rosselló, Gerard Plans Ahicart, M. Martínez García, Anna Esteve Gómez, Jordi Bruna Escuer

      • Resumen

      págs. 2104-2112

      

    • Development of a web‑based tool for estimating individualized survival curves in glioblastoma using clinical, mRNA, and tumor microenvironment features with fusion techniques

      Zunlan Zhao, Yujie Shi, Shouhang Chen, Yan Xu, Fangfang Fu, Chong Li, Xiao Zhang, Ming Li, Xiqing Li

      • Resumen

      págs. 2113-2126

      

    • Pyrimidine metabolism reshapes immune microenvironment and implies poor prognosis in glioma

      Runyu Huang, Jingchen Yang, Xuejing Li, Huiyuan Chen, Xing Liu

      • Resumen

      págs. 2127-2142

      

    • Early region‑specifc impact of adjuvant radiation therapy on cognition and quality of life in adult patients with primary brain tumors

      Beatriz Gutiérrez García, Cynthia Caceres Aguilar, Fidel Núñez Marín, Jaume Molero Savall, Luis Antonio Prats Sánchez, Neus Mestre Miralles, Silvia Martínez, P. Teixidor, S. Comas, Carmen Balaña Quintero, Salvador Villà Freixa

      • Resumen

      págs. 2143-2159

      

    • Caveolin‑1 modulates cisplatin sensitivity in oral squamous cell carcinoma through ferroptosis

      Weilin Zhang, Xinyi Yang, Wei Lin, Yang Yi, Hai Wu, Jianying Yang, Hongman Long, Guanglan Zou, Yadong Wu

      • Resumen

      págs. 2160-2173

      

    • Comparative study on the efcacy of low‑dose and full‑dose BCG bladder perfusion therapy

      Chaohu Chen, Guangrui Fan, Pan Li, Enguang Yang, Suoshi Jing, Yibo Shi, Yuwen Gong, Luyang Zhang, Zhiping Wang

      • Resumen

      págs. 2174-2190

      

    • Construction of M2 macrophage‑related gene signature for predicting prognosis and revealing diferent immunotherapy response in bladder cancer patients

      Zhouting Tuo, Mingzhu Gao, Chao Jiang, Duobing Zhang, Xin Chen, Zhiwei Jiang, Jinou Wang

      • Resumen

      págs. 2191-2206

      

    • Establishment of matched bladder cancer PDX and PDX‑derived organoid model and evaluation of anti‑tumor efcacy of abemaciclib

      Xiongbin Lu, Chao Hu, Lingxing Duan, Ke Cheng, Hua Hao, Yuanqiao He

      • Resumen

      págs. 2207-2219

      

    • Impact of COVID‑19 infection on genitourinary cancer management. SOGUG‑COVID‑19: a Spanish, multicenter, observational study

      Natalia Vidal, Miguel Ángel Climent Durán, Sara Pérez Ramírez, María José Méndez Vidal, Georgia Anguera Palacios, Imanol Martínez Salas, Enrique Gallardo-Díaz, Andrés Cuellar, Javier Molina Cerrillo, Almudena Martín Marino, Alejo Rodriguez Vida, Elena Almagro, Macarena González, Montserrat Domenech Santasusana, Mireia Martínez Kareaga, Ovidio Fernández Calvo, José Carlos Villa Guzmán, Sergio Vázquez Estévez, Aránzazu González del Alba

      • Resumen

      págs. 2220-2231

      

    • Real‑world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain

      Javier Puente Vázquez, Alvaro Pinto Marín, María José Méndez Vidal, Xavier García del Muro, Pablo Maroto Rey, Sergio Vázquez Estévez, Raquel Luque Caro, Urbano Anido Herranz, Torsten Strunz, Jose Montes, Aurora Ortiz Nuñez, Judit González Portela, Anil Upadhyay, Daniel Castellano-Gauna

      • Resumen

      págs. 2232-2240

      

    • Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy

      L. Osorio Cabello, Tatiana Paulina Grazioso Javier, Guillermo de Velasco Oria de Rueda, Olatz Etxaniz Ulazia, José Luis Pérez Gracia, Alvaro Pinto Marín, Ignacio Durán, Enrique Grande Pulido, Pablo Borrega García, Martin Lázaro Quintela, Laura Rodríguez Lajusticia, María Laura Villalobos León, Lourdes García, Andrés Cuellar, María del Pilar Solís Hernández, Cristina Pernaut Sánchez, Juan Francisco Rodríguez Moreno, Cristina Rodríguez Antona, Jesús García Donas

      • Resumen

      págs. 2241-2255

      

    • METTL3‑mediated m6A modifcation of ZNF384 promotes hepatocellular carcinoma progression by transcriptionally activating ACSM1

      Limei Zhang, Jinfu Wang, Fenfang Gui, Fanzhou Peng, Weiping Deng, Qian Zhu

      • Resumen

      págs. 2256-2268